Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/34427| Title: | ANTIBIOTICS: CURE AND RISK FACTOR FOR CLOSTRIDIOIDESDIFFICILE INFECTION | Authors: | Mihajlov, Kiril Trajkovska Dokikj, Elena Labachevska Gjatovska, Liljana Kostovski, Marko Jovchevski, Radomir Kovacheva Trpkovska, Danica Ignjatovikj Mihajlova, Ivana |
Keywords: | Clostridioides difficile infection C. difficile antimicrobial susceptibility |
Issue Date: | 22-Apr-2024 | Publisher: | Faculty of Medicine, Ss. Cyril and Methodius University in Skopje | Journal: | Academic Medical Journal | Abstract: | Introduction: The major risk factor for acquiring an infection with Clostridioides difficile (CDI) is a long-term antibiotic treatment. Contrarily, the treatment of severe CDI cases involves application of antibiotics like vancomycin or metronidazole. Our aim was to investigate the percentage of resistance to eight antibiotics (vancomycin, metronidazole, tetracycline, clindamycin, erythromycin, imipenem, ciprofloxacin and moxifloxacin) among Clostridioides difficile isolates, indirectly evaluating the risks of acquiring CDI and the risks of therapeutic failure. | URI: | http://hdl.handle.net/20.500.12188/34427 | DOI: | 10.53582/AMJ2441041m |
| Appears in Collections: | Faculty of Medicine: Journal Articles |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.